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Objective: The Society for Vascular Surgery (SVS) recently established the Lower Extremity Threatened Limb Classiﬁ-
cation System, a staging system using Wound characteristic, Ischemia, and foot Infection (WIfI) to stratify the risk for
limb amputation at 1 year. Although intuitive in nature, this new system has not been validated. The purpose of the
following study was to determine whether the WIfI system is predictive of limb amputation and wound healing.
Methods: Between 2007 and 2010, we prospectively obtained data related to wound characteristics, extent of infection,
and degree of postrevascularization ischemia in 139 patients with foot wounds who presented for lower extremity
revascularization (158 revascularization procedures). After adapting those data to the WIfI classiﬁcations, we analyzed
the inﬂuence of wound characteristics, extent of infection, and degree of ischemia on time to wound healing; empirical
Kaplan-Meier survival curves were compared with theoretical outcomes predicted by WIfI expert consensus opinion.
Results: Of the 158 foot wounds, 125 (79%) healed. The median time to wound healing was 2.7 months (range,
1-18 months). Factors associated with wound healing included presence of diabetes mellitus (P[ .013), wound location
(P[ .049), wound size (P[ .007), wound depth (P[ .004), and degree of ischemia (P < .001). The WIfI clinical stage
was predictive of 1-year limb amputation (stage 1, 3%; stage 2, 10%; stage 3, 23%; stage 4, 40%) and wound nonhealing
(stage 1, 8%; stage 2, 10%; stage 3, 23%; stage 4, 40%) and correlated with the theoretical outcome estimated by the SVS
expert panel.
Conclusions: The theoretical framework for risk stratiﬁcation among patients with critical limb ischemia provided by
the SVS expert panel appears valid. Further validation of the WIfI classiﬁcation system with multicenter data is
justiﬁed. (J Vasc Surg 2014;60:1535-42.)The Society for Vascular Surgery (SVS) Lower Extrem-
ity Guidelines Committee recently created the Lower Ex-
tremity Threatened Limb (Wound Ischemia foot
Infection [WIfI]) Classiﬁcation System, to stratify the risk
of limb amputation in the heterogeneous population of pa-
tients presenting with critical limb ischemia (CLI).1 The
SVS WIfI classiﬁcation system was developed by merging
the existing CLI and diabetic foot ulcer (DFU) classiﬁca-
tion systems.2-8
The purpose of this classiﬁcation system was not meant
to function as a stand-alone clinical decision-making tool
but to allow for better patient stratiﬁcation in clinical trials
designed to compare new strategies for treating CLI. The
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://dx.doi.org/10.1016/j.jvs.2014.08.107on three graded factors: wound characteristics, the degree
of pedal perfusion, and the extent of infection. Owing to
a paucity of natural history studies in patients with CLI,
the risks of limb amputation within the categories of this
new classiﬁcation system were estimated by a panel of ex-
perts using a Delphi consensus process. The theoretical as-
sumptions developed by this panel still await clinical
validation.
Our group has long sought to develop a CLI classiﬁca-
tion system that would help vascular surgeons predict the
likelihood of wound healing in patients with CLI and assist
them in evaluating patients for possible revascularization.9
In 2007, borrowing from the same literature used to
develop the SVS WIfI classiﬁcation system, we began col-
lecting data related to wound characteristics, degree of
ischemia, and extent of infection on patients presenting
with foot wounds; we also monitored them prospectively
The similarity of our collected data and the factors used
by the SVS WIfI classiﬁcation system provided a unique op-
portunity to use our study population to score patients ac-
cording to the SVS WIfI and to compare actual patient
outcomes with those predicted by the SVS panel of experts.
Thus, the purpose of this study was to provide early clinical
validation of the SVS WIfI classiﬁcation system.
METHODS
The Greenville Health System Institutional Review
Board for the study of human subjects approved this study
(IRB #14947). Patient consent was deemed unnecessary.1535
Table I. Comparison of study data categories with the Wound characteristic, Ischemia, and foot Infection (WIfI) grades
Study data categories WIfI
Wound characteristicsa Wound gradeb
Wound size 0 No rest pain
1 <1 cm2 1 Small, shallow ulcer
2 1-3 cm2 No exposed bone, unless limited to distal phalanx
3 >3 cm2 No gangrene
Wound depth 2 Deeper ulcer with exposed bone joint, or tendon, not
involving the tissue heel
1 Ulcer not extending to SQ Shallow heel ulcer without calcaneal involvement
2 Ulcer extending to SQ tissue Gangrenous changes limited to digits
3 Ulcer extending to bone or joint space 3 Extensive, deep ulcer involving forefoot/midfoot
Wound type Deep, full thickness heel ulcer þ calcaneal involvement
1 Ulcer Extensive gangrene involving forefoot/midfoot
2 Gangrene Full thickness heel necrosis þ calcaneal involvement
Location Infection grade
1 Forefoot 0 No symptoms or signs of infection
2 Midfoot 1 Local infection involving only skin, SQ tissue
3 Heel 2 Local infection with erythema >2 cm, or involving structures
deeper than skin, SQ (eg, abscess, osteomyelitis)
Infection categories 3 Local infection with signs of SIRS
1 None Ischemia grade
2 Erythema 0 TP >60 mm Hg
3 Purulence ABI >0.8
4 Systemic evidence of infection AP >100 mm Hg
Ischemia categoriesc 1 TP 40-59 mm Hg
1 TP >60 mm Hg ABI 0.6-0.79
ABI >0.9 AP 70-100 mm Hg
Palpable pulse 2 TP 30-39 mm Hg
AP >80 mm Hg ABI 0.4-0.59
2 TP 30-60 mm Hg AP 50-70 mm Hg
ABI 0.5-0.9 3 TP <30 mm Hg
AP 50-79 mm Hg ABI <0.39
3 TP <30 mm Hg AP <30 mm Hg
ABI <0.5
AP <50 mm Hg
ABI, Ankle-brachial index; AP, systolic ankle pressure; SIRS, systemic inﬂammatory response syndrome; SQ, subcutaneous tissue; TP, toe pressure.
aStudy only included patients with foot wounds.
bWIfI classiﬁcation dictates that wound depth take priority over wound size.
cIf ABI and TP resulted in different grades in patients with diabetes mellitus, TP was used to determine grade.
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Classiﬁcation System. Developed in 2013, the SVS WIfI
system provides an objective classiﬁcation for wound non-
healing and limb amputation based on three independent
risk factors: wound extent (eg, size, depth, presence of
gangrene), degree of ischemia, and extent of foot infection.
All three factors are individually graded on a scale of 0 to 3.
For example, a shallow, small foot ulcer would be classed as
a grade 1 wound (W-1), whereas a large wound extending
to the joint space with gangrene would be classed as a
grade 3 wound (W-3). Severity of ischemia and extent of
infection are likewise graded on scales from 0 to 3. A
detailed description of the SVS WIfI grading is presented
in Table I.
After a patient has been graded on each of the three
categories, the grades are combined to create a WIfI spec-
trum score. The expert consensus panel evaluated each
WIfI spectrum score to predict the risk of limb amputation
at 1 year and in a separate analysis, the likelihood that the
patient would beneﬁt from limb revascularization. A grid ofpotential WIfI spectrum scores, including the predictions
of the consensus panel regarding the risk of limb amputa-
tion at 1 year (very low risk, low risk, moderate risk, high
risk) for each score, is provided in Table II. The risk cate-
gory of a WIfI spectrum score determines the clinical stage
of disease. WIfI spectrum scores deemed to be very low risk
for limb amputation at 1 year are categorized as clinical
stage 1 disease. Spectrum scores deemed low risk, moder-
ate risk, and high risk for limb amputation at 1 year are
categorized as clinical stage 2, stage 3, and stage 4 disease,
respectively.
Patients. All patients presenting to our tertiary
referral center between June 2007 and March 2011
with CLI (Rutherford class V or VI) scheduled to un-
dergo a revascularization procedure were prospectively
collected in a database. Data related to foot wound char-
acteristics, extent of infection, and degree of ischemia
were entered into the database according to speciﬁc
categories. Those categories were similar but not iden-
tical to the grades used by the WIfI classiﬁcation system.
Table II. Consensus expert estimate of 1-year amputation risk based on the Wound characteristic, Ischemia, and foot
Infection (WIfI) Spectrum Score
W grade Ischemia 0 Ischemia 1 Ischemia 2 Ischemia 3
W-0 VL VL L M VL L M H L L M H L M M H
W-1 VL VL L M VL L M H L M H H M M H H
W-2 L L M H M M H H M H H H H H H H
W-3 M M H H H H H H H H H H H H H H
fI-0 fI-1 fI-2 fI-3 fI-0 fI-1 fI-2 fI-3 fI-0 fI-1 fI-2 fI-3 fI-0 fI-1 fI-2 fI-3
fI, Foot infection grade; H, high 1-year amputation risk; L, low 1-year amputation risk; M, moderate 1-year amputation risk; VL, very low 1-year amputation
risk; W, wound grade.
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WIfI grades is provided in Table I.
A vascular surgery faculty member or resident charac-
terized the foot wound and extent of infection. Photo-
graphs of the foot were obtained before the
revascularization procedure. After the revascularization
procedure, a pulse examination, the ankle-brachial index
(ABI), a toe pressure, and an absolute ankle pressure
were obtained to characterize pedal perfusion. Postproce-
dural wound management was not standardized.
The wound, perfusion, and infection data, along with
the photograph taken at the time of revascularization,
were used to assign a SVS WIfI wound, ischemia, and
infection grade. Those grades were combined to create a
WIfI spectrum score and clinical stage for each patient.
The predicted outcome for that clinical stage, as deter-
mined by the consensus panel of experts, was compared
with the actual outcome of the studied patients.
Data collection and primary end points. Collected
and analyzed data included patient demographics, comor-
bidities, intervention type, and outcomes. The diagnosis
of patient comorbidities (diabetes mellitus, hypertension,
hyperlipidemia, coronary artery disease, end-stage renal
disease) was established by history and the medical record.
Primary end points were wound nonhealing and major
limb amputation at 1 year. WIfI wound, ischemia, infection
grades, and spectrum scores were analyzed to determine
their relationship to primary end points. The study
excluded patients presenting with vasospastic and collagen
vascular disease, vasculitis, Buerger disease, acute limb
ischemia, atheroembolic disease, and arterial trauma.
This study did not analyze outcomes (eg, wound heal-
ing or amputation-free survival) by procedure type but
rather by the extent of pedal perfusion achieved after the
intervention. A number of patients underwent multiple
revascularization procedures, which changed the ischemia
score and potentially altered the course of wound healing
for those patients. Accordingly, rules were established to
account for three potential scenarios for patients who un-
derwent multiple revascularization procedures during
follow-up:
Scenario 1: If the secondary intervention happened
<6 weeks after the initial intervention, we used the
date of ﬁrst intervention as time 0 for calculatingtime-dependent outcomes and the best grade of the
two ischemic grades to determine the perfusion score.
For example, if the WIfI ischemia grade increased
from I-3 to I-2 after intervention, the I-2 grade was
used.
Scenario 2: If the secondary intervention happened
>6 weeks beyond the initial intervention and the
ischemia grade decreased or was unchanged after
the second intervention, we took the date of ﬁrst
intervention as time 0 for calculating time-
dependent outcomes and used the initial ischemia
grade to determine the perfusion score.
Scenario 3: If the secondary intervention happened
>6 weeks beyond the initial intervention, if the
wound had not healed at the time of the second
intervention, and if the ischemia grade increased to
a higher category after the second intervention,
then we determined the initial wound to be a failure
of wound healing and obligingly rescored the wound
at the second intervention to derive new wound,
perfusion, and infection grades. The time from the
ﬁrst to second intervention was used to calculate
time-dependent outcomes, with the date of the sec-
ond intervention becoming time 0 for calculating
time-dependent outcomes.
Statistical analysis. Bivariate analysis was performed
to determine factors crudely associated with wound heal-
ing and limb salvage using Kaplan-Meier life-table
methods and the log-rank test. Multivariate logistic
regression analysis was conducted to determine indepen-
dent predictors of outcome at 1 year (P < .05). Wound
characteristics, extent of infection, degree of ischemia, and
patient characteristics identiﬁed in bivariate analysis to be
associated with outcome were entered into the initial
model. A backward selection strategy was used to deter-
mine the ﬁnal model, with a P value #.05 required for
variables to remain in the model. Logistic regression was
used to evaluate the crude association of increasing the
WIfI clinical stage with wound healing and limb amputa-
tion at 12 months. Discrimination of the model was
evaluated according to the concordance index. All analyses
were completed with SAS 9.3 software (SAS Institute Inc,
Cary, NC). Statistical signiﬁcance was determined at an
a ¼ .05.
Fig. Flow diagram of study population.
Table III. Patient demographics and comorbidities
Variables No. (%) or mean 6 SD (N ¼ 139)
Wounds 158
Age, years 70 6 11
Gender
Female 53 (38)
Male 86 (62)
Race/ethnicity
African American 30 (22)
Caucasian 106 (76)
Hispanic 3 (2)
Smoking status
Never 48 (34)
Former 44 (32)
Current 47 (34)
Diabetes
None 48 (34)
Type 1 5 (4)
Type 2 78 (56)
Type unspeciﬁed 8 (6)
Hypertension 130 (93)
Hyperlipidemia 99 (71)
Coronary artery disease 87 (63)
End-stage renal disease 19 (14)
SD, Standard deviation.
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During the study period, 165 patients presenting with
a foot wound underwent an index revascularization proce-
dure for limb salvage, and 26 were excluded because they
were lost to follow-up (n ¼ 8), died #90 days of study
enrollment (n ¼ 9), or did not have a complete postproce-
dural noninvasive vascular examination (n ¼ 9). Of the
remaining 139 study patients, 120 had one ulcer, 12 had
bilateral lower extremity ulcers, and 7 had two ulcers on
the same extremity, of whom 2 patients developed a sec-
ond ulcer after healing of the ﬁrst, and in 5 patients an ulcer
was rescored after a second intervention (scenario 3 in
the Methods section). Therefore, 158 wounds were graded
and comprised the basis for this analysis (Fig). Mean
patient follow-up was 27.5 6 11 months.
Patient demographics with comorbidities are provided
in Table III. During the follow-up period, 62% of foot
wounds (98 of 158) were managed in a wound clinic.
Complete wound healing occurred in 79% (125 of 158),
with a median time to wound healing of 2.7 months
(range, 1-18 months). The overall amputation rate was
13% (20 amputations in 151 limbs at risk) at 1 year. Bivar-
iate analysis demonstrated that smoking (P ¼ .03), wound
size (P ¼ .02), wound depth (P ¼ .001), and ischemia (P <
.001) were crudely associated with wound healing. Smok-
ing (P ¼ .027), wound size (P ¼ .026), and ischemia (P <
.001) were also crude predictors of limb amputation.
Multivariate analysis showed that advanced ischemia and
infection grade were independently associated with
reduced wound healing and increased risk of amputation
at 1 year. Diabetes was also independently associated
with limb amputation at 1 year.
After we converted the wound, ischemia, and infection
data for the study cohort to WIfI grades and subsequently
to a WIfI clinical stage (1-4), the outcome of patientswithin each of those stages was compared (Tables IV and
V). Logistic regression analysis showed a statistically signif-
icant increase in limb amputation and a reduction in wound
healing at 1 year with an advanced WIfI clinical stage
(Table V).
A comparison of the predicted and observed 1-year
outcomes of limb amputation and wound healing by the
WIfI clinical stage is provided in Table VI. The predicted
vs observed outcome for limb amputation at 1 year for
each clinical stage was similar.
Table IV. Observed 1-year outcomes by Wound characteristic, Ischemia, and foot Infection (WIfI) clinical stage
WIfI clinical
stage
Wounds,
No.
Limbs at
risk, No.
Patients,
No.
Outcome at 1 year
Wound healing, No. (%) Limb salvage, No. (%) Amputation-free survival, No. (%)
Stage 1 40 37 36 37/40 (92.5) 36/37 (97.3) 31/36 (86.1)
Stage 2 64 63 58 50/64 (78.1) 56/63 (88.9) 48/58 (82.8)
Stage 3 46 43 37 30/46 (65.2) 33/43 (76.7) 26/37 (70.3)
Stage 4 8 8 8 3/8 (37.5) 5/8 (62.5) 3/8 (37.5)
Table V. Measured Wound characteristic, Ischemia, and
foot Infection (WIfI) clinical stage odds ratios (ORs) and
95% conﬁdence intervals (CIs) for wound healing and
limb loss #1 year
WIfI clinical
stage
1-year wound healing,
OR (95% CI)
1-year limb
amputation, OR (95% CI)
Stage 1 1.00 (Referent) 1.00 (Referent)
Stage 2 0.29 (0.08-1.08) 4.8 (0.6-40.5)
Stage 3 0.15 (0.04-0.57) 10.8 (1.3-88.8)
Stage 4 0.05 (0.01-0.31) 23.4 (2.2-270.2)
Concordance
index
0.69 0.71
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Innumerable prior studies have identiﬁed speciﬁc fac-
tors (eg, diabetes mellitus, ischemia, and infection) to be
associated with pedal wound nonhealing and limb amputa-
tion. Existing CLI and DFU classiﬁcation systems are
based on those same factors. Such classiﬁcation systems
stratify the risk of wound nonhealing and limb amputation
for clinical trials research comparing treatment modalities.
These systems may help guide therapy but have signiﬁcant
limitations, which were eloquently discussed by Mills et al1
in their article describing the WIfI classiﬁcation system.
Chief among the limitations of previous classiﬁcation sys-
tems is their failure to consider pedal perfusion and wound
characteristics on a spectrum of severity.
Current classiﬁcation systems, which include ischemia
as a factor in their risk stratiﬁcation, establish a speciﬁc cut-
off measurement of pedal perfusion (eg, ABI >0.75). Pedal
wounds with perfusion above that cutoff are expected to
heal, whereas those with perfusion below this critical cutoff
are expected not to heal and, ultimately, to result in limb
loss.
The notion that a speciﬁc cutoff measure exists has
been challenged by two studies that give some insight
into the natural history of CLI without revascularization.
Marston et al10 reported a series of 142 patients presenting
with both lower extremity wounds and lower extremity
ischemia (ABI <0.7 or toe pressure <50 mm Hg) who
were managed with meticulous wound care but no revascu-
larization procedure. At 12 months, 52% of the wounds
had healed, and only 23% required limb amputation.10
Elgzyri et al11 studied 602 patients with DFUs who hadtoe pressures <45 mm Hg or an ankle pressure <80 mm
Hg and did not undergo a revascularization procedure.
Wounds healed in 50% of patients, and only 17% required
a major limb amputation.11
The SVS Lower Extremity Guideline Committee
recognized the need for a new classiﬁcation system that
would consider the diversity of the CLI patient population
and the many factors that inﬂuence outcome. As a result,
the committee created a system that grades the extent of
tissue injury, the severity of ischemia, and the extent of
infection individually before then combining those grades
to derive a clinical severity stage from which predictions
regarding the risk of limb loss can be made. Their effort
was hampered by the absence of solid natural history
studies on which could be established the risk of their clin-
ical severity grades. Thus, the risk of each stratum was to be
assessed by a panel of experts using a Delphi consensus pro-
cess. The committee hopes to validate the system theoret-
ical predictions with data obtained from registries such as
the SVS Vascular Quality Initiative.
The impetus for our study happened in 2007. Both-
ered by the existing CLI and DFU classiﬁcation schemes,
each categorizing pedal perfusion by establishing a single
cutoff measurement, we reasoned that a reliable classiﬁca-
tion system that graded multiple factors shown to inﬂuence
wound healing and limb salvage could be a valuable man-
agement tool for selecting patients for intervention. We hy-
pothesized that wound size and location, wound depth and
location, and extent of active infection all probably play a
role in wound healing and that “minor” wounds might
well require lesser degrees of pedal perfusion.
Because the WIfI grades and the wound, ischemia, and
infection categories of our study were generated from the
same validated CLI and DFU classiﬁcation systems, it is
not surprising that the data categories of our study are
similar to the WIfI grades. However, the WIfI classiﬁcation
system is unique from other classiﬁcation systems in the
way it combines the wound, ischemia, and infection grades
to create the WIfI Clinical Spectrum Score. The spectrum
score, which was developed similar to the TMN staging
system for cancer, predicts the risk of limb amputation at
1 year. The similarities between our data categories and
the WIfI grades made it fairly easy to convert our data to
WIfI grades and thus obtain a WIfI clinical spectrum score
and clinical stage for each patient. Patient outcomes (limb
amputation and wound nonhealing at 1 year) for each WIfI
Table VI. Comparison of expert predicted and data derived 1-year outcomes (limb amputation, wound nonhealing) by
Wound characteristic, Ischemia, and foot Infection (WIfI) clinical stage from Kaplan-Meier life table analysis
Estimated WIfI classiﬁcation No.
Predicted outcome, % Observed outcome, %
Limb amputation Limb amputation Nonhealed wound
Stage 1every low risk 40 w3 3 6 3 8 6 4
Stage 2elow risk 64 w8 10 6 4 19 6 5
Stage 3emoderate risk 46 w25 23 6 6 30 6 7
Stage 4ehigh risk 8 w50 40 6 22 63 6 21
JOURNAL OF VASCULAR SURGERY
1540 Cull et al December 2014clinical stage were compared with the outcomes predicted
by the SVS panel of experts.
Our study shows that wound size, depth, degree of
ischemia, and extent of infection correlate with wound
healing and limb salvage. This is not at all surprising
because similar ﬁndings have been shown in other studies
and form the basis of previous CLI and DFU classiﬁcation
systems. However, our study also shows that the WIfI clin-
ical stage outcome predictions of the expert panel for the
1-year amputation rate parallel the actual outcomes of pa-
tients in our study. Although the WIfI classiﬁcation system
was designed as a predictive model for limb salvage at
1 year, as well as an estimation of likelihood of beneﬁt of
revascularization, we found that the WIfI clinical stage
also correlated quite nicely with wound healing rates,
which arguably is an even more important patient-
centered outcome for most than mere limb survival.
One major difference between the data we gathered
and WIfI system bears mentioning. The WIfI system is
designed so that the wound, infection, and ischemia
grading are all performed before a revascularization proce-
dure and are then measured again after the procedure. In
designing our study to measure the effect of ischemia on
wound healing, we were unwilling to simply observe
wounds with moderate and severe degrees of ischemia for
patients we thought would beneﬁt from a revascularization
procedure. As such, our study measured pedal perfusion af-
ter the revascularization procedure. We reasoned that the
ischemia score after the revascularization procedure would
provide a reasonable approximation of the likelihood of
wound healing for those patients who had an incomplete
revascularization outcome. In other words, our study as-
sumes that the ischemia grade dictates the likelihood of
wound healing and limb amputation regardless of whether
the patient had a revascularization procedure.
One might argue that a minor improvement in tissue
perfusion after a revascularization procedure could be
enough to change the healing of a wound. However, we
believe an intervention that results in only marginal
improvement in measurable tissue perfusion will likely have
a negligible inﬂuence on wound healing. Because the natural
history data are lacking on the relationship of wound dimen-
sions, the extend of ischemia, and infection, we believe that
our method of measuring perfusion after revascularization is
a better method for validating WIfI clinical stage outcomespredicted by the panel of experts. As studies are developed
to ultimately validate the WIfI classiﬁcation system, this issue
will need to be addressed. Finding an adequately sized pop-
ulation of patients with wounds having marginal circulation
who are willing to forego treatment to establish WIfI valida-
tion may be difﬁcult.
Our study has several limitations. Given the variability
of patients who present with CLI and the many factors
that are involved in wound healing and limb salvage, our
study lacks an adequate number of patients to fully validate
the WIfI Classiﬁcation System. Nevertheless, our study
does indicate that the consensus panel’s estimates of ampu-
tation risk at each WIfI clinical stage are accurate. In a sepa-
rate analysis, the WIfI consensus panel also estimated the
likelihood of patient beneﬁt from revascularization at
each WIfI clinical stage. Our study was not able to validate
this latter issue nor is it clear how such a determination can
be accomplished.
Our study is also limited by the small number of patients
with WIfI clinical stage 4 disease and severe infection (WIfI
infection grade 4). There are two explanations for this.
Firstly, our study only included patients who underwent a
revascularization procedure. Patients who were nonambula-
tory, deemed unsuitable for revascularization, required “he-
roic” efforts to achieve limb salvage (eg, extensive wounds
extending to the calcaneous), or presented with large
wounds associated with ﬂorid sepsis, were only offered
amputation rather than an attempt at limb salvage and
accordingly were excluded. Secondly, our protocol directed
that wound and infection assessment be done at the time of
the revascularization procedure. Infection in most patients
had been controlled with antibiotics, incision with drainage,
and amputation before the revascularization procedure.
Our study also lacked a standard method of wound
management. Factors such as the wound dressing, control
of edema, and patient compliance with oral antibiotics can
inﬂuence wound healing. Some studies have shown the
use of negative pressure wound therapy and hyperbaric ox-
ygen therapy beneﬁts healing of chronic lower extremity
wounds in patients with diabetes mellitus.12-15 We assumed
that our study patients received “optimal” wound care,
although such management varied considerably. Sixty-two
percent of patients in our series received care in a wound
clinic where they were seen weekly until the wound healed.
Some patients in our series received negative pressure
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to treat the wounds with those modalities were usually
determined by the wound characteristics and the patient’s
insurance status. Such differences among study patients like-
wise might have inﬂuenced our limb salvage and wound
healing rates. When future studies using the WIfI classiﬁca-
tion system to evaluate treatment modalities for CLI are
developed, a standardized wound management protocol
should be adopted to mitigate the effects of this potential
confounding variable that could inﬂuence outcome.
The WIfI classiﬁcation system recommends noting
whether neuropathy is present. We did not evaluate patients
for the presence or absence of neuropathy. Although origi-
nally included as a factor in our study, it was soon aban-
doned due to inconsistency in grading among physicians.
Finally, the inclusion of multiple limbs and wounds
from a single patient resulted in a larger analytic sample
and could constitute a lack of independence of observa-
tions. Therefore, we conducted a similar set of analyses
including only a single wound per patient (n ¼ 139). Esti-
mated odds ratios from both analyses were similar; howev-
er, the precision of these estimates was generally improved
when including multiple wounds and limbs.
CONCLUSIONS
Our study provides early clinical validation of the WIfI
classiﬁcation system. The 1-year limb salvage rate for pa-
tients in our series correlated not only with the WIfI clinical
stage but also with the outcome predicted by the panel of
experts who established the WIfI. Our study also showed
that the WIfI clinical stage correlated with wound healing.
Multicenter studies comprising more patients are justiﬁed
to fully validate the WIfI classiﬁcation system. In the
future, once additional components such as a patient risk
index are added to the WIfI classiﬁcation system, the sys-
tem holds promise as a tool for comparing treatment mo-
dalities in clinical trials and as a clinical decision-making
tool for guiding therapy in patients with CLI.
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Submitted Jun 9, 2014; accepted Aug 26, 2014.DISCUSSIONDrRichardNeville (Washington, D.C.). DrCull, I thoroughly
appreciate this important work on wound analysis from your
group. I have two questions: First, what methodology did you
use to actually measure the wound? Was it largest transverse diam-
eter? Do you have a reproducible way to measure the wounds? Sec-
ondly, with this type of study it is interesting to note the wound
care the patients received. Did the study involve protocol-driven
wound care for each patient to assure a standard approach? Forexample, did some patients get free ﬂaps, some rotational ﬂaps,
or some people just got wet-to-dry dressings? How did you
account for the different kinds of wound care?
Dr David L. Cull. We calculated the area by multiplying the
length and width of the wound. Your second question regarding
the wound care each patient received is important. Wound care
was not standardized in this study. We made the assumption that
all patients received optimal wound care; however, this assumption
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care treatment while others were not. Some patients received hyper-
baric oxygen therapy or negative pressure wound therapy, while
others did not. This is a limitation of our study. Sixty-two percent
of patients received wound care in a wound care clinic. When we
ran the bivariate analysis, we were surprised to learn that the patients
who received treatment in the wound care clinic did poorer than
those who did not. But on further analysis, we found that the
wound care clinic patients tended to have larger wounds.
Dr Anil Hingorani (Brooklyn, NY). Just one brief question
about the Wound characteristic, Ischemia, and foot Infection
(WIfI) system. Were you able to identify a subset of patients
who did not do welld90% of them did not heal, 90% of them
ended up with limb loss? In your data set you said your stage 4 pa-
tients were 50/50.
Dr Cull. Although our study showed that only 40% of stage 4
patients ultimately ended up with an amputation at 1 year, our
study methodology most certainly underestimated limb amputa-
tion for that stage. Our study only included patients who under-
went a revascularization procedure. Because most patients
presenting with stage 4 disease were not offered a revascularization
procedure but rather underwent primary limb amputation, they
were not included. Had they been included, the outcome for the
stage 4 category would have been much worse.
Dr Frank Logerfo (Boston, Mass). This is a terriﬁc effort on
the part of the Society to deﬁne what patients we should operate
on and to some extent what operation we should do. People
with diabetes and a foot ulcer, who have signiﬁcant ischemia,
that means you cannot feel a pulse in the foot, should just go right
to revascularization. With diabetes, the neuroinﬂammatory
response is lost and we cannot measure the total baseline biological
impairment or the susceptibility of the diabetic foot to ischemia.
Therefore the term “critical ischemia” becomes undeﬁnable. If
someone has a foot ulcer and you cannot feel a pulse, whatever
is going on in that foot, it cannot remain healed in daily life.
The measurable circulation may be identical in two people but
“critical” in one but not the other, depending on the baseline bio-
logical impairment. Some people with diabetes can have perfect
circulation and still have foot ulcers because they have no neuroin-
ﬂammatory response and no somatic neurologic sensation.In your data, the patients I would look at most carefully are
those in the lower classiﬁcations that wound up with amputation.
Why did that happen and have you looked in detail at each of
them?
Dr Cull. Since there were so few limb amputations in the
stage 1 and 2 categories, we were unable to go into any more
detail, beyond the analysis we did, to further reﬁne the WIfI clas-
siﬁcation. The variability of patients presenting with limb threat
makes such analysis difﬁcult. Full validation of the WIfI classiﬁca-
tion system will take many more patients than were generated by
our study. Your statement that all diabetic patients with a foot ul-
cer who do not have a pulse should undergo revascularization is a
principle I have followed for the ﬁrst 15 years of my practice. In
2007, we decided to challenge that principle with the hypothesis
that a small wound that is not infected requires less perfusion to
heal than a large wound or an infected wound. That hypothesis
is the foundation of the WIfI classiﬁcation system. Our study seems
to validate that hypothesis.
Dr Pierre Karam (Montreal, Quebec, Canada). I have two
questions. The ﬁrst is how practical is it to apply the WIfI system
in our practice? And the second question, in the subgroup of pa-
tients with end-stage renal disease, do you have any data on how
they correlate with the WIfI staging?
Dr Cull. The bivariate analysis did not show that patients
with end-stage renal disease fared any worse than those patients
without renal disease. This could be due to selection bias.
Again, our study only included patients who underwent a
revascularization procedure. It is possible that patients with
end-stage renal disease were only offered a revascularization
procedure in selective cases where a favorable outcome was
more certain.
Regarding your question on how practical it is to obtain the
information in order to obtain a WIfI clinical stage, we found
the process of grading the wound, the degree of ischemia, and
the extent of infection both quick and easy. On paper, the staging
looks more arduous than it is in practice. In the future, the Society
for Vascular Surgery Lower Extremity Guidelines Committee
hopes to add anatomic information and a patient comorbidity in-
dex in order to create a tool to guide therapy. That will add a layer
of complexity to the model.
